Skip to main content
Fig. 1 | BMC Pulmonary Medicine

Fig. 1

From: Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: a case-control study

Fig. 1

Multivariate analysis of clinical characteristics associated with adverse cardiovascular events. BMI, body mass index; FEV1, forced expiratory volume in 1 second; DM, diabetes mellitus; CVD, cardiovascular disease; CKD, chronic kidney disease; LAMA, long-acting muscarinic antagonists; LABA, long-acting beta2-agonists; ICS, inhaled corticosteroids; CI: confidence interval. ** p < 0.001. *p < 0.05

Back to article page